JKJashwant Kumar

Jashwant Kumar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jashwant Kumar has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Optimizing monoclonal antibody biosimilar production via transfer and active learning for targeted quality profiles

    by Jashwant Kumar, Reema Sultana, Deeksha Saripalla, Viki Chopda, Velu Mahalingam, Laxmi Adhikary

    Biosimilar development of monoclonal antibodies (mAbs) is gaining significant momentum as numerous blockbuster biologics approach their patent expiry in the current decade. A critical challenge in biosimilar development lies in achieving product quality attributes(PQAs) comparable to the innovator product. PQAs in upstream processing are influenced by multiple factors, including cell line selection, media composition, feeding strategy, supplements, and bioreactor process parameters, with physical parameter optimization playing a pivotal role in enhancing both product titer and modulating PQAs. In this study, we systematically evaluated the impact of physical process parameters—pH and temperature along with initial seeding density (ISD)—on N‐glycan profiles and charge variants across four biosimilar development projects (Projects 1–4). Stepwise regression models were developed between process parameters and product quality attributes using JMP software to establish parameter‐attribute relationships. Our results demonstrated that lowering culture pH reduced %acidic variants and %galactosylation while increasing %basic variants and %afucosylation (AF). Increased culture temperature resulted in an increase in %acidic variants and a decrease in %AF. This parameter‐attribute relationships knowledge base was directly applied in experimental design to expedite the development of a fifth mAb biosimilar development (Project 5), substantially reducing experimental iterations and development timelines, exemplifying the practical implementation of Bioprocessing 4.0 principles.


  • Open Access

    Optimizing mAb Biosimilar Production via Transfer and Active Learning for Fine-Tuning Physical Process Parameters for achieving Targeted N-Glycan and Charge Variant Profiles: Advancing Bioprocess 4.0

    by Jashwant Kumar, Reema Sultana, Deeksha Saripalla, Viki Chopda, Laxmi Adhikary

    Biosimilar development of monoclonal antibodies (mAbs) is gaining significant momentum as numerous blockbuster biologics approach their patent expiry in the current decade. A critical challenge in biosimilar development lies in achieving product quality attributes comparable to the innovator product. The product quality attributes (PQAs) in upstream processing are influenced by multiple factors, including cell line selection, media composition, feed strategy, supplements, and bioreactor process parameters, with physical parameter optimization playing a pivotal role in enhancing both product titer and modulating PQAs. In this study, we systematically evaluated the impact of physical process parameters - pH, temperature, and initial seeding density - on N-glycan profiles and charge variants across four biosimilar development projects (Projects 1-4). Prediction models were developed using JMP software to establish parameter-attribute relationships. Our results demonstrated that lowering bioreactor pH reduced % acidic variants and % Afucosylation (AF) while increasing % basic variants and % galactosylation. Similarly, increased culture temperature resulted in lower % acidic variants and % AF. This knowledge base was successfully applied to expedite the development of a fifth mAb biosimilar development (Project 5), substantially reducing experimental iterations and development timelines, exemplifying the practical implementation of Bioprocessing 4.0 principles.


  • Supplementation of critical amino acids improves glycerol and lactose uptake and enhances recombinant protein production in Escherichia coli

    by Jashwant Kumar, Ashish S. Chauhan, Jaya A. Gupta, Anurag S. Rathore

    Background: Lactose‐based induction strategy in E. coli cultivation has several advantages over IPTG as it is cheap, does not impart metabolic stress to cells, and is non‐toxic to cells. However, complexity of lactose as an inducer limits its application in fed‐batch cultivation. A mixed glycerol‐lactose based induction strategy is generally opted during fed‐batch cultivation of E. coli. However, slow growth of E. coli in glycerol and lactose results in slower induction of heterologous protein.Main Methods and Major Results: In this study, initially we have demonstrated supplementation of critical amino acids (AAs) improves uptake rate of glycerol and lactose in wildtype E. coli BL21(DE3) in defined medium. A feeding strategy of mixed glycerol‐lactose feed along with supplement of critical AAs enhances recombinant production of pramlintide multimer (rPramlintide). High cell density cultivation of E. coli using mixed glycerol‐lactose feed and critical AAs supplement resulted in final cell density of 52.2 ± 0.90 g L−1 and rPramlintide titer of 7.8 g L−1. RT‐qPCR analysis of genes involved in glycerol and lactose metabolism of recombinant culture showed upregulation with AAs supplementation.Conclusions and Implications: We hypothesize that supplementation of critical AAs serves dual purpose: (i) faster assimilation of carbon sources, and (ii) combating metabolic stress arises due to AAs starvation. The substrate uptake and gene expression profiles demonstrate that AAs addition enhances glycerol and lactose assimilation due to overall improvement in their metabolism governed by global regulators of carbon metabolism.